Dr. Srinivas Tantravahi
Claim this profileHuntsman Cancer Institute
Studies Myelofibrosis
Studies Chronic Myeloid Leukemia
10 reported clinical trials
23 drugs studied
Area of expertise
1Myelofibrosis
Stage I
Stage II
CD4 positive
2Chronic Myeloid Leukemia
BCR-ABL1 positive
b3a2 (e14a2) positive
b2a2 (e13a2) positive
Affiliated Hospitals
Clinical Trials Srinivas Tantravahi is currently running
Blinatumomab + Chemotherapy
for Leukemia
This phase III trial compares the effect of usual treatment of chemotherapy and steroids and a tyrosine kinase inhibitor (TKI) to the same treatment plus blinatumomab. Blinatumomab is a Bi-specific T-Cell Engager ('BiTE') that may interfere with the ability of cancer cells to grow and spread. The information gained from this study may help researchers determine if combination therapy with steroids, TKIs, and blinatumomab work better than the standard of care.
Recruiting2 awards Phase 310 criteria
Asciminib + Imatinib
for Chronic Myeloid Leukemia
This is a single arm phase II study that will enroll a minimum of 47 subjects with a maximum of 51. All patients will have a confirmed diagnosis of chronic phase chronic myeloid Leukemia and must have previously attempted to discontinue Tyrosine Kinase inhibitors (TKI). All patients must have restarted the same TKI they were on prior to discontinuation at the time of relapse in order to be eligible for this trial.
Recruiting1 award Phase 220 criteria
More about Srinivas Tantravahi
Clinical Trial Related4 years of experience running clinical trials · Led 10 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Srinivas Tantravahi has experience with
- Selinexor
- Imatinib
- Asciminib
- Dasatinib
- Ruxolitinib
- Iptacopan
Breakdown of trials Srinivas Tantravahi has run
Myelofibrosis
Chronic Myeloid Leukemia
Chronic Illness
Primary Myelofibrosis
Chronic Myelogenous Leukemia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Srinivas Tantravahi specialize in?
Srinivas Tantravahi focuses on Myelofibrosis and Chronic Myeloid Leukemia. In particular, much of their work with Myelofibrosis has involved Stage I patients, or patients who are Stage II.
Is Srinivas Tantravahi currently recruiting for clinical trials?
Yes, Srinivas Tantravahi is currently recruiting for 2 clinical trials in Salt Lake City Utah. If you're interested in participating, you should apply.
Are there any treatments that Srinivas Tantravahi has studied deeply?
Yes, Srinivas Tantravahi has studied treatments such as Selinexor, Imatinib, Asciminib.
What is the best way to schedule an appointment with Srinivas Tantravahi?
Apply for one of the trials that Srinivas Tantravahi is conducting.
What is the office address of Srinivas Tantravahi?
The office of Srinivas Tantravahi is located at: Huntsman Cancer Institute, Salt Lake City, Utah 84112 United States. This is the address for their practice at the Huntsman Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.